Charles Schwab Investment Management Inc Vir Biotechnology, Inc. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,142,879 shares of VIR stock, worth $6.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,142,879
Previous 1,293,016
11.61%
Holding current value
$6.43 Million
Previous $6.52 Million
0.14%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
106MCall Options Held
246KPut Options Held
126K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$93.9 Million0.72% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$92.5 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$72.7 Million32.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$72.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.24MShares$29.5 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $747M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...